Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-01

Clinical Trial Update: Clinical Research of Tapering UDCA in PBC Patients With a Complete Response [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tapering ursodeoxycholic acid in primary biliary cholangitis patients who have achieved a complete response. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Biliary Cholangitis | Phase 4 | Status: RECRUITING